("AfriAg Global" or the "Company")
These funds will be used to pursue new investments that fit with the Company’s existing investment strategy and will also be applied to potential new investments in the medical cannabis sector should shareholders approve of the expanded investment strategy when it is put to shareholders shortly.
The Subscription Shares will represent 17.04% of the enlarged issued share capital of the Company.
Following Admission, the Company's enlarged issued share capital will comprise 1,761,001,037 ordinary shares. The Company does not hold any shares in treasury.
This figure of 1,761,001,037 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the
The directors of the Company accept responsibility for the contents of this announcement.
For further information please contact:
Afriag Global Plc: +44 (0)20 7440 0640 David Lenigas(Executive Chairman) Peterhouse Capital Limited+44 (0)20 7469 0930 Guy Miller Fungai Ndoro
Notes to Editors:
The Company’s global distribution footprint has expanded considerably over the years, moving and distributing perishable food products by road, air and sea for many blue-chip companies around the globe.
AfriAg Global’s 100% owned subsidiary, AfriAg Marketing recorded revenues of £3.122 million for 2017, with its 40% owned agri-logistics group